Lupin, Biocon, Dr Reddy Share Price Jump as Nifty Pharma Rallies 3% on US–India Trade Deal

Pharmaceutical stocks surged on Tuesday, February 3, after the US and India reached a trade deal that lowered tariffs on Indian exports to 18% from the earlier 50%. The move lifted sentiment across pharma counters.

At around 9:30 am, the Nifty Pharma index was up nearly 3%, outperforming the broader market. In comparison, the Nifty 50 was trading about 2.7% higher.

Lupin, Biocon, Dr Reddy’s Lead Gains

Several pharma stocks saw strong buying interest. Aurobindo Pharma and Wockhardt jumped nearly 5%. Dr Reddy’s, Sun Pharma, Divi’s Laboratories, Piramal Pharma and Mankind Pharma gained over 3%.

Stocks such as Lupin, Biocon, Glenmark Pharma, Zydus Lifesciences and Alkem Laboratories were also up more than 2%.

Also Read: Best Long-Term Stocks in Jan 2026 – 5yr CAGR Basis!

Conclusion

The sharp rally in pharma stocks reflects optimism around improved margins and earnings after the US–India trade deal. With lower tariffs easing export pressures, US-focused pharma companies are likely to remain in focus in the near term.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.